Genzyme Corporation Convenes 4th Annual Gaucher Leadership Forum in Munich

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the fourth annual Gaucher Leadership Forum (GLF) will take place on September 21 and 22 in Munich, Germany. The GLF is a scientific meeting sponsored by Genzyme that brings together more than 200 participants from around the world, including physicians, academics, researchers and patient organization representatives to discuss current care for patients with Gaucher disease and the direction of future disease management. This year’s GLF is chaired by Dr. Pram Mistry, Professor of Pediatrics and Internal Medicine, Director of the National Gaucher Disease Treatment Center and Chief of Pediatric Gastroenterology/Hepatology at Yale University School of Medicine.
MORE ON THIS TOPIC